Short answer
PUMA BIOTECHNOLOGY, INC. (PBYI) filed an 8-K current report with the SEC on May 7, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 financial results for quarter ended March 31, 2026.
PUMA BIOTECHNOLOGY, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 financial results for quarter ended March 31, 2026
- Press release furnished as Exhibit 99.1 contains detailed operating and financial results
- Investor focus: quarterly performance, cash position, and product revenue trends disclosed in the exhibit
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PUMA BIOTECHNOLOGY, INC. 8-K filings
Get the next PBYI 8-K as it lands
Follow PBYI for push alerts, or ask the research agent what this filing means.